Blackberry Soars on Morgan Stanley Upgrades

Michael Teague |

Blackberry Soars on Morgan Stanley UpgradesAfter beginning the year amid uncertainty about its very future, Blackberry (BBRY) broke out of its slow rally of the last few weeks into a full sprint today, with the news that the brokerage firm Morgan Stanley upgraded the stock from “underweight” to “overweight” while doubling its price targets from $10 per share to $22 per share.



The company’s share price shot up 8.85 percent to $16.31, trading nearly 6 million shares above its 3-month average volume of 64,857,300 on the news in midday, and a week ahead of a fourth quarter earnings report that is expected to give investors their first look at how the company’s new Z10 phone is selling abroad.  The highly anticipated Z10’s official release in the U.S. comes at the end of the week.

Stanley analyst Ehud Gelblum explained the twin upgrades by citing the new phone’s potential to increase profit margins, allowing the company to remain competitive without necessarily having to outperform or out-innovate gigantic rivals like Apple (AAPL) and Samsung.

The upgrade comes not long after Goldman Sachs (GS) similarly increased the stock’s price target to $19 back at the end of January.

CEO Thorston Heins was confident about the company’s future, saying “I shake my head sometimes and wonder what everyone is talking about. The company has no debt, I will report pretty good cash position by the end of March in my earnings call, so I think we did a really diligent job in, not just keeping the company afloat, but also bringing it back to health.”

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Companies

Symbol Name Price Change % Volume
AAPL Apple Inc. 153.61 -0.26 -0.17 21,927,637 Trade
MS Morgan Stanley 42.84 0.21 0.49 5,346,476 Trade
TIPT Tiptree Financial Inc. 6.30 0.05 0.80 11,533 Trade
GS The Goldman Sachs Group Inc. 223.53 1.06 0.48 1,787,060 Trade
BBRY BlackBerry Limited 11.11 -0.11 -0.98 10,412,970 Trade

Comments

Emerging Growth

Immunovaccine Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.

Private Markets

Initial State

Initial State is an Internet of Things (IoT) data analytics & data management platform company. We turn sensor and event data into information that matters by making it easy to…

Mesa-Marshall 2 Well Project

MESA Resources ("MESA") is sponsoring the development of the two well direct drilling project -- "Mesa-Marshall #1-2". MESA, founded in 1992, is engaged in the acquisition, exploration and development of…